← Open Payments lookup

ERIC NGHE: Open Payments

NPI 1417466368 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,600 in 45 payments from 7 companies in 2025. Trend: 2023 $893 · 2024 $1,440 · 2025 $1,600

Food & beverage: $1,600
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$369
Axsome Therapeutics, Inc.14$302
Otsuka America Pharmaceutical, Inc.5$292
ABBVIE INC.8$246
Vanda Pharmaceuticals Inc.7$205
Lundbeck LLC6$147
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40

Products named: REXULTI, Auvelity, VRAYLAR, UZEDY, FANAPT, AUSTEDO XR, CAPLYTA.

Industry payments across CA — which companies pay providers there.